» Articles » PMID: 32604941

Update on the Effects of Antioxidants on Diabetic Retinopathy: In Vitro Experiments, Animal Studies and Clinical Trials

Overview
Date 2020 Jul 2
PMID 32604941
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Current therapies for diabetic retinopathy (DR) incorporate blood glucose and blood pressure control, vitrectomy, photocoagulation, and intravitreal injections of anti-vascular endothelial growth factors or corticosteroids. Nonetheless, these techniques have not been demonstrated to completely stop the evolution of this disorder. The pathophysiology of DR is not fully known, but there is more and more evidence indicating that oxidative stress is an important mechanism in the progression of DR. In this sense, antioxidants have been suggested as a possible therapy to reduce the complications of DR. In this review we aim to assemble updated information in relation to in vitro experiments, animal studies and clinical trials dealing with the effect of the antioxidants on DR.

Citing Articles

Effects of Selected Antioxidants on Electroretinography in Rodent Diabetic Retinopathy.

Dutczak R, Pietrucha-Dutczak M Antioxidants (Basel). 2025; 14(1).

PMID: 39857355 PMC: 11762402. DOI: 10.3390/antiox14010021.


Comparative Efficacy of Low-Carbohydrate and Ketogenic Diets on Diabetic Retinopathy and Oxidative Stress in High-Fat Diet-Induced Diabetic Rats.

Jawharji M, Alshammari G, Binobead M, Albanyan N, Al-Harbi L, Yahya M Nutrients. 2024; 16(18).

PMID: 39339674 PMC: 11435414. DOI: 10.3390/nu16183074.


From Vineyard to Vision: Efficacy of Maltodextrinated Grape Pomace Extract (MaGPE) Nutraceutical Formulation in Patients with Diabetic Retinopathy.

Schiano E, Vaccaro S, Scorcia V, Carnevali A, Borselli M, Chisari D Nutrients. 2024; 16(17).

PMID: 39275167 PMC: 11397461. DOI: 10.3390/nu16172850.


Diabetic Retinopathy: New Treatment Approaches Targeting Redox and Immune Mechanisms.

Tang Q, Buonfiglio F, Bohm E, Zhang L, Pfeiffer N, Korb C Antioxidants (Basel). 2024; 13(5).

PMID: 38790699 PMC: 11117924. DOI: 10.3390/antiox13050594.


Oxidative Stress Mediates Epigenetic Modifications and the Expression of miRNAs and Genes Related to Apoptosis in Diabetic Retinopathy Patients.

Karam-Palos S, Andres-Blasco I, Campos-Borges C, Zanon-Moreno V, Gallego-Martinez A, Alegre-Ituarte V J Clin Med. 2024; 13(1).

PMID: 38202081 PMC: 10780047. DOI: 10.3390/jcm13010074.


References
1.
Madsen-Bouterse S, Zhong Q, Mohammad G, Ho Y, Kowluru R . Oxidative damage of mitochondrial DNA in diabetes and its protection by manganese superoxide dismutase. Free Radic Res. 2010; 44(3):313-21. PMC: 3025400. DOI: 10.3109/10715760903494168. View

2.
Lin J, Bierhaus A, Bugert P, Dietrich N, Feng Y, vom Hagen F . Effect of R-(+)-alpha-lipoic acid on experimental diabetic retinopathy. Diabetologia. 2006; 49(5):1089-96. DOI: 10.1007/s00125-006-0174-y. View

3.
Kusuhara S, Fukushima Y, Ogura S, Inoue N, Uemura A . Pathophysiology of Diabetic Retinopathy: The Old and the New. Diabetes Metab J. 2018; 42(5):364-376. PMC: 6202564. DOI: 10.4093/dmj.2018.0182. View

4.
Shanab A, Nakazawa T, Ryu M, Tanaka Y, Himori N, Taguchi K . Metabolic stress response implicated in diabetic retinopathy: the role of calpain, and the therapeutic impact of calpain inhibitor. Neurobiol Dis. 2012; 48(3):556-67. DOI: 10.1016/j.nbd.2012.07.025. View

5.
Kheirouri S, Naghizadeh S, Alizadeh M . Zinc supplementation does not influence serum levels of VEGF, BDNF, and NGF in diabetic retinopathy patients: a randomized controlled clinical trial. Nutr Neurosci. 2018; 22(10):718-724. DOI: 10.1080/1028415X.2018.1436236. View